Carlina Develops Anticancer Nanocapsules For Pets And Patients
This article was originally published in The Pink Sheet Daily
Executive Summary
French drug delivery firm Carlina is developing new lipid-based nanoparticle formulations of cancer drugs for pets and patients, and aims to build a proprietary pipeline with the help of collaborations with other companies.